Kushner to Asharq Al-Awsat: The US Plan Is Not a Bribe

White House senior adviser Jared Kushner gives a speech at the opening of the "Peace to Prosperity" conference in Manama, Bahrain, June 25, 2019 in this still image taken from a video. Reuters TV via REUTERS
White House senior adviser Jared Kushner gives a speech at the opening of the "Peace to Prosperity" conference in Manama, Bahrain, June 25, 2019 in this still image taken from a video. Reuters TV via REUTERS
TT

Kushner to Asharq Al-Awsat: The US Plan Is Not a Bribe

White House senior adviser Jared Kushner gives a speech at the opening of the "Peace to Prosperity" conference in Manama, Bahrain, June 25, 2019 in this still image taken from a video. Reuters TV via REUTERS
White House senior adviser Jared Kushner gives a speech at the opening of the "Peace to Prosperity" conference in Manama, Bahrain, June 25, 2019 in this still image taken from a video. Reuters TV via REUTERS

US President Donald Trump’s adviser and son-in-law, Jared Kushner, said his economic plan to support the Palestinians proposes a new approach to resolving the Palestinian-Israeli conflict and that its implementation should come in parallel with the political aspect of what he calls the “deal of the century.”

In an interview with Asharq Al-Awsat, Kushner said the Manama workshop achieved “tremendous success” and that all attendees agreed that economic transformation in the West Bank and Gaza Strip was possible and reliant on political stability and security.

Noting that participants came “from all over the world,” the US senior official said that the gathering of the business community was a new approach to resolving the conflict.

He stressed that in the past, the diplomatic community failed to achieve success, and that it was repeating the same policy today.

“It is a waste of everyone's time,” he said.

Kushner explained that the economic community was looking at the prospects for security, peace and good governance, adding that shifting the Palestinian economy was possible. He also said that his economic plan was “very detailed and reasonable.”

“After extensive review, people were very positive about it and considered it achievable,” he underlined.

Responding to a question about the plan’s non-referral to settlements, occupation and checkpoints, which makes it appear detached from its political and security context, Kushner said the plan pointed to crossing points that should be invested in to facilitate transit.

He added that the presence of "solid" borders fell within Israel’s attempt to protect itself from terrorism, noting that although the proportion of people willing to commit terrorist acts was very small, the rest unfortunately paid the price.

“As for other issues, this plan is not political. So I think those who criticize the plan for this reason do not realize the purpose of this economic effort,” he told Asharq Al-Awsat.

Kushner said he believed the Israelis were impressed with the plan’s details and all-inclusiveness.

“I think the Israelis are very happy to be in Bahrain,” he added.

The US presidential adviser pointed to the rapprochement between Arab countries and Israel over the past few years.

“I think it is imperative that this region be united. When that happens, it will unleash enormous economic potential and greatly expand security,” he stressed.

Commenting on claims that the US was trying to “bribe” neighboring countries through this economic plan to settle Palestinian refugees, Kushner said the economic plan was not a bribe, but an opportunity to enable people to overcome problems that have plagued them for a long time.

He emphasized that the plan would not be implemented but in parallel with a political solution, “but at the same time we cannot just settle for a political solution without improving people’s lives, because that will hinder the political solution.”

Asked to explain his earlier statements that the US peace plan would not be in line with the Arab Peace Initiative, Kushner said that although the Arab initiative was a good effort, it was met with rejection.

“In order to reach an agreement, concessions should be made by both sides,” he remarked.

On the Arab reactions to the US economic plan, Trump’s son-in-law asserted that everyone who attended the workshop and looked at the 140-page document said that the plan was largely feasible and brought new ideas to solve the crisis.

“There is a great desire among the Gulf States to help the Palestinian people, and I think they see in this plan a framework to help them do this,” he noted.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.